MoneyWorks4Me

Zydus Lifesciences informs about press release

04 Oct 2022 Evaluate
Zydus Lifesciences has informed that it enclosed a copy of press release dated October 4, 2022 titled ‘Zydus receives tentative approval from the USFDA for Amantadine Extended-Release Capsules’.

The above information is a part of company’s filings submitted to BSE.



Peers
Company Name CMP
Sun Pharma. Inds. 1745.00
Dr. Reddys Labs. 1242.00
Cipla 1331.00
Lupin 1953.75
Zydus Lifesciences 1113.00
View more..